新青年麻醉论坛

 找回密码
 会员注册

QQ登录

只需一步,快速开始

快捷登录

搜索
热搜: 麻醉 视频 中级
查看: 5112|回复: 1
打印 上一主题 下一主题

[English Forum] ANZCA1999 Q 澳纽专科考试试题 1999年--肥胖患者的麻醉

[复制链接]
跳转到指定楼层
1#
发表于 2010-6-23 17:55:41 | 只看该作者 回帖奖励 |倒序浏览 |阅读模式
本帖最后由 shenxiu2 于 2010-6-23 20:33 编辑

1999A01: A 52 year old man, height 1.75m, weighing 130 kg presents for laparoscopic cholecystectomy under general anaesthesia. History and examination reveal no other abnormality. How does this patient's obesity influence your management of his anaesthetic up to the time of the first incision?


Obesity is a complex, multi-factorial disease, defined as a body weight 20% greater than ideal body weight. It can also be classified using the Body Mass Index (BMI) where: BMI = weight (kg) / height2 (m).

Obese: BMI > 30

Morbidly obese: BMI > 40

This patient has a BMI of 42, meeting criteria for morbid obesity.

Obesity is associated with increased peri-operative mortality and morbidity. This will influence the anaesthetic in the following ways:

Pre-operative assessment [presumably this has already been done?]

-
Introduce self and obtain inform consent.

-
Assess for comorbidities (see below)

-
Assess for difficult airway – Mallampati score, thyromental distance, inter-incisor distance.

-
Investigations

o
Random blood glucose: looking for unidentified diabetes.

o
FBC: Hb, looking for polycythaemia associated with sleep apnoea.

o
Electrolytes: looking for indication of renal disease, which may be associated with diabetes.

o
ECG: looking for signs of ischaemic heart disease and past AMIs.

o
CXR: looking for heart size, as indicative of CCF.

Physiological changes of obesity

  • Lung volumes – decreased FRC leads to lower oxygen stores and more rapid desaturation with apnoea, as may occur at induction.
  • Lung compliance (decreased) and resistance (increased) requiring higher pressures for ventilation (IPPV).
  • Gastric emptying decreased due to increased intraabdominal pressures, possibly increasing aspiration risk.
  • Increased blood volume.

Pharmaceutical changes of obesity

  • Increased volume of distribution.
  • Decreased total body water.
  • Decreased hepatic blood flow.
  • Drug doses should be based upon lean body weight not actual weight.

Associated co-morbidities of obesity

  • Obstructive sleep apnoea and ‘obesity hypoventilation syndrome’
    • 2-4% of the normal adult population and 5% of the obese.
    • Associated with: hypertension, hypoxaemia, hypercarbia and polycythaemia.
    • Increased sensitivity to CNS depressant drugs, increasing risk of post-operative respiratory failure.
  • Diabetes mellitus

·
Associated with ischaemic heart disease, increased wound infection, poor wound healing.

  • Hypertension – increasing blood pressure lability intra-operatively.
  • Ischaemic heart disease – obesity is an independent risk factor.
  • Congestive cardiac failure – LV hypertrophy worsens LV compliance, which combined with hypervolaemia leads to CCF.
  • Pulmonary hypertension – due to combined chronic hypoxaemia and increased pulmonary blood volume. May lead to right heart failure.
  • Thromboembolic disease – increased risk of DVT/PE due to polycythaemia, increased abdominal pressure, immobilisation.

Anaesthetic management

  • Planning

·
Pre-medication

o
Acid prophylaxis – metoclopramide, ranitidine, sodium citrate.

o
Anti-sialogogue (glycopyrrolate) if planning FOB intubation.

·
Patient will require close monitoring post-operatively, as at high risk of peri-operative hypoxia in first 5 days. Suggest monitor in HDU if bed available for first 24 hours.

·
If using CPAP device at home, own machine should be used in hospital. If not requiring CPAP, facility should be available post-operatively in case of respiratory decline.

·
Not suitable for day surgery.

  • Technique

·
Consider regional technique if appropriate (not suitable here for lap cholecystectomy).

·
Mandatory intubation given further increased intra-abdominal pressure and possible increased risk of aspiration.

  • Extra monitoring

·
5-lead ECG to detect cardiac ischaemia

·
Invasive blood pressure monitoring may be required if either i) associated ischaemic heart disease, ii) NIBP cuff unsuitable due to patient size. If planned post-op HDU admission, also assists in HDU monitoring.

  • Induction

·
If predicted difficult intubation, awake fibre optic intubation is indicated. Otherwise a rapid sequence induction is suitable.

·
Set-up of theatre for possible difficult intubation is essential (ideal positioning with pillows to provide support; access to bougie, alternate laryngoscopes, etc.)

·
Induction with propofol may offer a faster emergence than thiopentone.

  • Maintenance

·
Use non-narcotic analgesia (paracetamol, NSAIDs, COX-2, local anaesthetic infiltration) and shorter-acting narcotics, such as fentanyl.

·
Use short-acting neuromuscular blocking agents.

·
For a short-medium length case such as this, choice of volatile agent (isoflurane, sevoflurane, desflurane) will have little impact on speed of recovery.

  • Emergence [ not for this answer ]

·
Mandatory reversal of neuromuscular blockade.

·
Extubate when fully awake.

楼主热帖

马上注册,享用更多功能,让你轻松玩转论坛

您需要 登录 才可以下载或查看,没有帐号?会员注册

x

有奖活动:我为论坛出谋划策!! ←点击查看详情

2#
发表于 2010-7-19 21:49:49 | 只看该作者
52岁男患,高1.75米,重130公斤,欲全麻下行腹腔镜胆囊切除术,病史检查无异常,病人的肥胖怎样影响你的麻醉管理。
肥胖是复杂的 多因素疾病。超过理想体重的20%即定为肥胖,亦通过体重指数(BMI)进行分类 BMI=体重/身高的平方
BMI >30 肥胖
BMI>40 病态肥胖
此病历的指数是42 是严重的病态肥胖
肥胖和增加的围手术期死亡和发病率有关,在以下各方面影响麻醉:
1、术前评估
病情介绍和知情同意

评分

1

查看全部评分

活动公告:做任务得积分和权限(新手奖励计划) (←点击查看详情)

回复 支持 反对

使用道具 举报/纠错

您需要登录后才可以回帖 登录 | 会员注册

本版积分规则

收藏帖子 返回列表 联系我们 搜索 官方QQ群

QQ|关于我们|业务合作|手机版|新青年麻醉论坛 ( 浙ICP备19050841号-1 )

GMT+8, 2025-1-23 20:23 , Processed in 0.158548 second(s), 30 queries , Gzip On.

Powered by Discuz! X3.2

© 2001-2013 Comsenz Inc.

快速回复 返回顶部 返回列表